A diagnosis of rheumatoid arthritis, endometriosis or IBD is associated with later onset of fibromyalgia and chronic widespread pain
article
OA: closed
CC0
⤵ 8 in-corpus citations
AI-generated summary
Rheumatoid arthritis, endometriosis, and inflammatory bowel disease are risk factors for developing fibromyalgia and chronic widespread pain later in life.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Widespread pain is a common comorbidity in several chronic diseases and is suspected to be caused by pain resulting from the underlying disease that has provoked a state of central sensitization. However, this argument is currently limited by evidence that has insufficiently captured the temporal nature of the relationship between diagnosis of the underlying disease and onset of widespread pain. The aim of this study was to investigate if patients with rheumatoid arthritis (RA), endometriosis or inflammatory bowel disease (IBD), have a higher risk of developing widespread pain (fibromyalgia or chronic widespread pain [CWP]). METHODS: Using the Swedish Skåne Healthcare register on health care consultation, a cohort of 889,938 adult patients were followed from 2007 to 2016 and incident cases of RA, endometriosis or IBD and of fibromyalgia and CWP were identified by registered diagnoses. Using Poisson regression, we calculated incidence rate ratios (IRR) adjusted for sex, age, education and propensity to seek health care. RESULTS: For patients with RA the IRR for later fibromyalgia was 3.64 (95% CI: 2.75-4.81) compared to patients without RA, for CWP it was 2.96 (95% CI: 1.81-4.86). For endometriosis patients the IRR for fibromyalgia was 2.83 (95% CI: 1.96-4.08) and for CWP 5.02 (95% CI: 3.10-8.13). IBD patients had an IRR = 2.32 (95% CI: 1.58-3.42) for fibromyalgia and 1.42 (95% CI: 0.93-2.17) for CWP. CONCLUSIONS: This study shows that RA, endometriosis and IBD are all risk factors for later fibromyalgia and CWP, consistent with a hypothesis of central sensitization as an effect of a painful underlying condition. SIGNIFICANCE: We show that RA, endometriosis and IBD predisposes for later fibromyalgia and CWP, a common hypothesis previously difficult to verify due to lack of longitudinal data. The results inform further research regarding the aetiology of fibromyalgia and CWP and stress the need of clinical focus on the pain itself in chronic diseases with pain as a symptom.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (48)
- Assessing the prevalence of autoimmune, endocrine, gynecologic, and psychiatric comorbidities in an ethnically diverse cohort of female fibromyalgia patients: does the time from hysterectomy provide a clue? via openalex
- Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences via openalex
- Differences in characteristics among 1,000 women with endometriosis based on extent of disease via openalex
- High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis via openalex
- Pathogenesis of endometriosis: The role of initial infection and subsequent sterile inflammation (Review) via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study via openalex
- W1751248490 via openalex
- W1905072234 via openalex
- W1950256523 via openalex
- W1983455946 via openalex
- W1986079650 via openalex
- W1998713427 via openalex
- W2000061875 via openalex
- W2039321614 via openalex
- W2046537974 via openalex
- W2049056319 via openalex
- W2056108471 via openalex
- W2063553068 via openalex
- W2063586401 via openalex
- W2072239292 via openalex
- W2080900225 via openalex
- W2089480099 via openalex
- W2092344668 via openalex
- W2137498790 via openalex
- W2139902503 via openalex
- W2143663503 via openalex
- W2147184115 via openalex
- W2153669860 via openalex
- W2161320464 via openalex
- W2161826146 via openalex
- W2232978449 via openalex
- W2253364553 via openalex
- W2513715080 via openalex
- W2740581884 via openalex
- W2794034677 via openalex
- W2804213423 via openalex
- W2868233831 via openalex
- W6600709116 via openalex
- W7073844826 via openalex
- W905985 via openalex
- W7074037168 via openalex
- W17639579 via openalex
- W197200243 via openalex
- W978402759 via openalex
- W1440648612 via openalex
- W1671027704 via openalex
- W1725312953 via openalex
Cited by (8)
- Endometriosis and fibromyalgia co-occurrence: A comparative study of patient history and clinical profile 2025
- Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
- Insights from Mendelian randomization and genetic correlation analyses into the relationship between endometriosis and its comorbidities 2023
- Spatiotemporal Trends and Age–Period–Cohort Analysis for the Burden of Endometriosis-Related Infertility: An Analysis of the Global Burden of Disease Study 2019 2023
- Questionnaires for the Assessment of Central Sensitization in Endometriosis: What Is the Available Evidence? A Systematic Review with a Narrative Synthesis 2023
- Trends in pelvic pain symptoms over 2 years of follow-up among adolescents and young adults with and without endometriosis 2022
- Pathophysiology, diagnosis, and management of endometriosis 2022
- Endometriose und chronische überlappende Schmerzsyndrome 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:48.502547+00:00
License: CC0
· commercial use OK